Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cisplatin (platinol) (1 trial)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (1 trial)
Carcinoma, Transitional Cell (Phase 3)
Kidney Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (3 total)